Evidence map›Paper›PMID 38201535›Full record

ArticleCancers2023

SkinLesNet: Classification of Skin Lesions and Detection of Melanoma Cancer Using a Novel Multi-Layer Deep Convolutional Neural Network.

Muhammad Azeem, Kaveh Kiani, Taha Mansouri, Nathan Topping

Open access · goldAbstract read
In one paragraph

Article in Cancers, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
11.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 50 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Muhammad AzeemSchool of Science, Engineering & Environment, University of Salford, Manchester M5 4WT, UK.
Kaveh KianiSchool of Science, Engineering & Environment, University of Salford, Manchester M5 4WT, UK.ORCID 0000-0003-4541-5907
Taha MansouriSchool of Science, Engineering & Environment, University of Salford, Manchester M5 4WT, UK.ORCID 0000-0003-1539-5546
Nathan ToppingSchool of Science, Engineering & Environment, University of Salford, Manchester M5 4WT, UK.
University of Salford · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Skin cancer is a widespread disease that typically develops on the skin due to frequent exposure to sunlight. Although cancer can appear on any part of the human body, skin cancer accounts for a significant proportion of all new cancer diagnoses worldwide. There are substantial obstacles to the precise diagnosis and classification of skin lesions because of morphological variety and indistinguishable characteristics across skin malignancies. Recently, deep learning models have been used in the field of image-based skin-lesion diagnosis and have demonstrated diagnostic efficiency on par with that of dermatologists. To increase classification efficiency and accuracy for skin lesions, a cutting-edge multi-layer deep convolutional neural network termed SkinLesNet was built in this study. The dataset used in this study was extracted from the PAD-UFES-20 dataset and was augmented. The PAD-UFES-20-Modified dataset includes three common forms of skin lesions: seborrheic keratosis, nevus, and melanoma. To comprehensively assess SkinLesNet's performance, its evaluation was expanded beyond the PAD-UFES-20-Modified dataset. Two additional datasets, HAM10000 and ISIC2017, were included, and SkinLesNet was compared to the widely used ResNet50 and VGG16 models. This broader evaluation confirmed SkinLesNet's effectiveness, as it consistently outperformed both benchmarks across all datasets.

Indexed as

computer-aided diagnosiscomputer visionconvolutional neural networkdeep learningmedical imagingmelanomaskin cancerskin lesion

Identifiers

PMID38201535
PMCPMC10778045
OpenAlexW4390175204

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.